Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DRIXORAL PLUS

ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE

Standard Dose
500MG;3MG;60MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DRIXORAL PLUS is listed in Drugs@FDA under application 019453 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 500MG;3MG;60MG Sponsor SCHERING PLOUGH Submission history Latest submission status date: 2003-03-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview DRIXORAL PLUS is listed in Drugs@FDA under application 019453 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 500MG;3MG;60MG Sponsor SCHERING PLOUGH Submission history Latest submission status date: 2003-03-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.